SALT LAKE CITY, Jan. 13, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reviewed the encouraging survival rate from clinical research on children and adolescents with cancer as reported by Dusseldorf University Medical School. The University treats childhood cancer using multiple modalities, including hyperthermia therapy delivered by systems manufactured by BSD Medical, to provide a quality of life and standard of care that brings children from across Europe and elsewhere in the world to the University for treatment.
